vs

Side-by-side financial comparison of Emerson Electric (EMR) and Tapestry, Inc. (TPR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $2.5B, roughly 1.7× Tapestry, Inc.). Tapestry, Inc. runs the higher net margin — 22.4% vs 13.9%, a 8.5% gap on every dollar of revenue. On growth, Tapestry, Inc. posted the faster year-over-year revenue change (14.0% vs 4.1%). Tapestry, Inc. produced more free cash flow last quarter ($1.0B vs $602.0M). Over the past eight quarters, Tapestry, Inc.'s revenue compounded faster (29.9% CAGR vs -0.3%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

Tapestry, Inc. is a leading American multinational luxury fashion holding company. It owns three iconic lifestyle brands: Coach, Kate Spade New York, and Stuart Weitzman, offering premium handbags, apparel, footwear, accessories, and fragrances to global consumers via physical retail stores and e-commerce platforms.

EMR vs TPR — Head-to-Head

Bigger by revenue
EMR
EMR
1.7× larger
EMR
$4.3B
$2.5B
TPR
Growing faster (revenue YoY)
TPR
TPR
+9.9% gap
TPR
14.0%
4.1%
EMR
Higher net margin
TPR
TPR
8.5% more per $
TPR
22.4%
13.9%
EMR
More free cash flow
TPR
TPR
$435.5M more FCF
TPR
$1.0B
$602.0M
EMR
Faster 2-yr revenue CAGR
TPR
TPR
Annualised
TPR
29.9%
-0.3%
EMR

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
EMR
EMR
TPR
TPR
Revenue
$4.3B
$2.5B
Net Profit
$605.0M
$561.3M
Gross Margin
53.2%
75.5%
Operating Margin
17.8%
28.6%
Net Margin
13.9%
22.4%
Revenue YoY
4.1%
14.0%
Net Profit YoY
3.4%
80.8%
EPS (diluted)
$1.07
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
TPR
TPR
Q4 25
$4.3B
$2.5B
Q3 25
$4.9B
$1.7B
Q2 25
$4.6B
$1.7B
Q1 25
$4.4B
$1.6B
Q4 24
$4.2B
$2.2B
Q3 24
$4.6B
$1.5B
Q2 24
$4.4B
$1.6B
Q1 24
$4.4B
$1.5B
Net Profit
EMR
EMR
TPR
TPR
Q4 25
$605.0M
$561.3M
Q3 25
$637.0M
$274.8M
Q2 25
$586.0M
$-517.1M
Q1 25
$485.0M
$203.3M
Q4 24
$585.0M
$310.4M
Q3 24
$996.0M
$186.6M
Q2 24
$329.0M
$159.3M
Q1 24
$501.0M
$139.4M
Gross Margin
EMR
EMR
TPR
TPR
Q4 25
53.2%
75.5%
Q3 25
51.9%
76.3%
Q2 25
52.6%
76.3%
Q1 25
53.5%
76.1%
Q4 24
53.5%
74.4%
Q3 24
51.3%
75.3%
Q2 24
52.8%
74.9%
Q1 24
52.2%
74.7%
Operating Margin
EMR
EMR
TPR
TPR
Q4 25
17.8%
28.6%
Q3 25
16.4%
19.3%
Q2 25
16.1%
-33.9%
Q1 25
14.2%
16.0%
Q4 24
18.6%
22.4%
Q3 24
14.7%
16.7%
Q2 24
10.4%
14.8%
Q1 24
16.2%
13.8%
Net Margin
EMR
EMR
TPR
TPR
Q4 25
13.9%
22.4%
Q3 25
13.1%
16.1%
Q2 25
12.9%
-30.0%
Q1 25
10.9%
12.8%
Q4 24
14.0%
14.1%
Q3 24
21.6%
12.4%
Q2 24
7.5%
10.0%
Q1 24
11.4%
9.4%
EPS (diluted)
EMR
EMR
TPR
TPR
Q4 25
$1.07
$2.68
Q3 25
$1.12
$1.28
Q2 25
$1.04
$-2.30
Q1 25
$0.86
$0.95
Q4 24
$1.02
$1.38
Q3 24
$1.74
$0.79
Q2 24
$0.57
$0.67
Q1 24
$0.87
$0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
TPR
TPR
Cash + ST InvestmentsLiquidity on hand
$1.1B
Total DebtLower is stronger
$7.6B
$2.4B
Stockholders' EquityBook value
$20.3B
$551.2M
Total Assets
$41.9B
$6.5B
Debt / EquityLower = less leverage
0.37×
4.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMR
EMR
TPR
TPR
Q4 25
$1.1B
Q3 25
$743.2M
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.0B
Q3 24
$7.3B
Q2 24
$7.2B
Q1 24
$7.4B
Total Debt
EMR
EMR
TPR
TPR
Q4 25
$7.6B
$2.4B
Q3 25
$8.9B
$2.4B
Q2 25
$8.3B
$2.4B
Q1 25
$8.2B
$2.4B
Q4 24
$6.6B
$2.4B
Q3 24
$7.7B
$7.0B
Q2 24
$7.1B
$6.9B
Q1 24
$7.6B
$7.7B
Stockholders' Equity
EMR
EMR
TPR
TPR
Q4 25
$20.3B
$551.2M
Q3 25
$20.3B
$399.5M
Q2 25
$19.9B
$857.8M
Q1 25
$19.2B
$1.5B
Q4 24
$20.5B
$1.3B
Q3 24
$21.6B
$3.0B
Q2 24
$20.8B
$2.9B
Q1 24
$20.9B
$2.8B
Total Assets
EMR
EMR
TPR
TPR
Q4 25
$41.9B
$6.5B
Q3 25
$42.0B
$6.4B
Q2 25
$42.5B
$6.6B
Q1 25
$42.0B
$7.3B
Q4 24
$42.6B
$7.3B
Q3 24
$44.2B
$13.7B
Q2 24
$45.6B
$13.4B
Q1 24
$46.4B
$13.7B
Debt / Equity
EMR
EMR
TPR
TPR
Q4 25
0.37×
4.32×
Q3 25
0.44×
5.95×
Q2 25
0.42×
2.77×
Q1 25
0.42×
1.59×
Q4 24
0.32×
1.78×
Q3 24
0.36×
2.35×
Q2 24
0.34×
2.39×
Q1 24
0.36×
2.77×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
TPR
TPR
Operating Cash FlowLast quarter
$699.0M
$1.1B
Free Cash FlowOCF − Capex
$602.0M
$1.0B
FCF MarginFCF / Revenue
13.9%
41.5%
Capex IntensityCapex / Revenue
2.2%
1.7%
Cash ConversionOCF / Net Profit
1.16×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$4.4B
$1.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
TPR
TPR
Q4 25
$699.0M
$1.1B
Q3 25
$3.1B
$112.6M
Q2 25
$1.1B
$446.8M
Q1 25
$241.0M
$144.3M
Q4 24
$777.0M
$506.0M
Q3 24
$3.3B
$119.5M
Q2 24
$1.1B
$256.0M
Q1 24
$743.0M
$97.8M
Free Cash Flow
EMR
EMR
TPR
TPR
Q4 25
$602.0M
$1.0B
Q3 25
$2.7B
$80.2M
Q2 25
$977.0M
$411.5M
Q1 25
$154.0M
$113.4M
Q4 24
$694.0M
$475.1M
Q3 24
$2.9B
$93.9M
Q2 24
$998.0M
$209.8M
Q1 24
$661.0M
$78.8M
FCF Margin
EMR
EMR
TPR
TPR
Q4 25
13.9%
41.5%
Q3 25
54.9%
4.7%
Q2 25
21.5%
23.9%
Q1 25
3.5%
7.2%
Q4 24
16.6%
21.6%
Q3 24
63.1%
6.2%
Q2 24
22.8%
13.2%
Q1 24
15.1%
5.3%
Capex Intensity
EMR
EMR
TPR
TPR
Q4 25
2.2%
1.7%
Q3 25
8.9%
1.9%
Q2 25
2.0%
2.0%
Q1 25
2.0%
2.0%
Q4 24
2.0%
1.4%
Q3 24
9.1%
1.7%
Q2 24
2.1%
2.9%
Q1 24
1.9%
1.3%
Cash Conversion
EMR
EMR
TPR
TPR
Q4 25
1.16×
1.93×
Q3 25
4.86×
0.41×
Q2 25
1.83×
Q1 25
0.50×
0.71×
Q4 24
1.33×
1.63×
Q3 24
3.35×
0.64×
Q2 24
3.31×
1.61×
Q1 24
1.48×
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

TPR
TPR

Coach$1.4B57%
Other$787.0M31%
Kate Spade Company$290.0M12%

Related Comparisons